Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 328 entries
View as:

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04205968 Org: User:
Start: 06/01/20 End: 06/16/25 Due: 06/16/26

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00788580 Org: User:
Start: - End: - Due: -

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00016965 Org: User:
Start: 07/31/01 End: 04/30/06 Due: 04/30/07

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05364645 Org: User:
Start: 07/25/22 End: 05/01/29 Due: 05/01/30

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05040360 Org: User:
Start: 05/05/22 End: 03/31/27 Due: 03/31/28

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00946712 Org: User:
Start: 07/15/09 End: 02/08/22 Due: 02/08/23

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT00049335 Org: User:
Start: 02/28/03 End: 06/30/07 Due: 06/30/08

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00004001 Org: User:
Start: 10/31/99 End: 01/31/07 Due: 01/31/08

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003908 Org: User:
Start: 11/30/99 End: 01/31/07 Due: 01/31/08

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Phase: N/A Priority: Normal
NCT ID: NCT02785913 Org: User:
Start: 11/30/14 End: 11/30/19 Due: 11/30/20

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT05642611 Org: User:
Start: 06/06/23 End: 08/30/31 Due: 08/30/32

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT00012363 Org: User:
Start: 04/30/01 End: 04/30/06 Due: 04/30/07

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Phase: N/A Priority: Normal
NCT ID: NCT00919139 Org: User:
Start: 11/30/03 End: 11/30/10 Due: 11/30/11

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03768414 Org: User:
Start: 02/07/19 End: 10/28/24 Due: 10/28/25

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01668719 Org: User:
Start: 11/30/12 End: 12/31/25 Due: 12/31/26

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00017147 Org: User:
Start: 09/30/01 End: 11/30/12 Due: 11/30/13

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00288054 Org: User:
Start: 04/30/06 End: 04/30/12 Due: 04/30/13

S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00025493 Org: User:
Start: 10/31/01 End: 06/30/08 Due: 06/30/09

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT05642572 Org: User:
Start: 05/05/23 End: 05/31/27 Due: 05/31/28

S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01131221 Org: User:
Start: 06/30/10 End: 09/30/11 Due: 09/30/12

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00686166 Org: User:
Start: 02/28/09 End: 03/31/18 Due: 03/31/19

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00118105 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00874211 Org: User:
Start: 12/31/08 End: 06/30/19 Due: 06/30/20

S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00066794 Org: User:
Start: 07/31/04 End: 01/31/10 Due: 01/31/11

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05561387 Org: User:
Start: 10/12/23 End: 05/30/31 Due: 05/30/32